<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-02-01" modified="2020-10-07" version="188">
<accession>P98082</accession>
<accession>A6NES5</accession>
<accession>Q13598</accession>
<accession>Q9BTY0</accession>
<accession>Q9UK04</accession>
<name>DAB2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Disabled homolog 2</fullName>
</recommendedName>
<alternativeName>
<fullName>Adaptor molecule disabled-2</fullName>
</alternativeName>
<alternativeName>
<fullName>Differentially expressed in ovarian carcinoma 2</fullName>
<shortName>DOC-2</shortName>
</alternativeName>
<alternativeName>
<fullName>Differentially-expressed protein 2</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">DAB2</name>
<name type="synonym">DOC2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Genomics" volume="33" first="207" last="213">
<title>Sequence, genomic structure, and chromosomal assignment of human DOC-2.</title>
<authorList>
<person name="Albertsen H.M."/>
<person name="Smith S.A."/>
<person name="Melis R."/>
<person name="Williams B."/>
<person name="Holik P."/>
<person name="Stevens J."/>
<person name="White R."/>
</authorList>
<dbReference type="PubMed" id="8660969"/>
<dbReference type="DOI" id="10.1006/geno.1996.0185"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1998" name="Oncogene" volume="16" first="2381" last="2387">
<title>DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer.</title>
<authorList>
<person name="Mok S.C."/>
<person name="Chan W.Y."/>
<person name="Wong K.-K."/>
<person name="Cheung K.K."/>
<person name="Lau C.C."/>
<person name="Ng S.W."/>
<person name="Baldini A."/>
<person name="Colitti C.V."/>
<person name="Rock C.O."/>
<person name="Berkowitz R.S."/>
</authorList>
<dbReference type="PubMed" id="9620555"/>
<dbReference type="DOI" id="10.1038/sj.onc.1201769"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>ALTERNATIVE SPLICING</scope>
<source>
<tissue>Ovary</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1999" name="Oncogene" volume="18" first="3104" last="3113">
<title>Disabled-2 inactivation is an early step in ovarian tumorigenicity.</title>
<authorList>
<person name="Fazili Z."/>
<person name="Sun W."/>
<person name="Mittelstaedt S."/>
<person name="Cohen C."/>
<person name="Xu X.-X."/>
</authorList>
<dbReference type="PubMed" id="10340382"/>
<dbReference type="DOI" id="10.1038/sj.onc.1202649"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2000" name="Genomics" volume="70" first="381" last="386">
<title>Structure, sequence, and promoter analysis of human disabled-2 gene (DAB2).</title>
<authorList>
<person name="Sheng Z."/>
<person name="He J."/>
<person name="Tuppen J.A."/>
<person name="Sun W."/>
<person name="Fazili Z."/>
<person name="Smith E.R."/>
<person name="Dong F.B."/>
<person name="Xu X.-X."/>
</authorList>
<dbReference type="PubMed" id="11161789"/>
<dbReference type="DOI" id="10.1006/geno.2000.6383"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 3)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nature" volume="431" first="268" last="274">
<title>The DNA sequence and comparative analysis of human chromosome 5.</title>
<authorList>
<person name="Schmutz J."/>
<person name="Martin J."/>
<person name="Terry A."/>
<person name="Couronne O."/>
<person name="Grimwood J."/>
<person name="Lowry S."/>
<person name="Gordon L.A."/>
<person name="Scott D."/>
<person name="Xie G."/>
<person name="Huang W."/>
<person name="Hellsten U."/>
<person name="Tran-Gyamfi M."/>
<person name="She X."/>
<person name="Prabhakar S."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caoile C."/>
<person name="Challacombe J.F."/>
<person name="Chan Y.M."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Goodstein D."/>
<person name="Grigoriev I."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Martinez D."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nandkeshwar R."/>
<person name="Noonan J.P."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Predki P."/>
<person name="Priest J."/>
<person name="Ramirez L."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Yang J."/>
<person name="Dickson M."/>
<person name="Cheng J.-F."/>
<person name="Eichler E.E."/>
<person name="Olsen A."/>
<person name="Pennacchio L.A."/>
<person name="Rokhsar D.S."/>
<person name="Richardson P."/>
<person name="Lucas S.M."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
</authorList>
<dbReference type="PubMed" id="15372022"/>
<dbReference type="DOI" id="10.1038/nature02919"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1994" name="Gynecol. Oncol." volume="52" first="247" last="252">
<title>Molecular cloning of differentially expressed genes in human epithelial ovarian cancer.</title>
<authorList>
<person name="Mok S.C."/>
<person name="Wong K.-K."/>
<person name="Chan R.K.W."/>
<person name="Lau C.C."/>
<person name="Tsao S.-W."/>
<person name="Knapp R.C."/>
<person name="Berkowitz R.S."/>
</authorList>
<dbReference type="PubMed" id="8314147"/>
<dbReference type="DOI" id="10.1006/gyno.1994.1040"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 44-304 (ISOFORM 1)</scope>
<source>
<tissue>Ovary</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2000" name="Biochem. J." volume="347" first="613" last="621">
<title>Cytosolic adaptor protein Dab2 is an intracellular ligand of endocytic receptor gp600/megalin.</title>
<authorList>
<person name="Oleinikov A.V."/>
<person name="Zhao J."/>
<person name="Makker S.P."/>
</authorList>
<dbReference type="PubMed" id="10769163"/>
<dbReference type="DOI" id="10.1042/bj3470613"/>
</citation>
<scope>INTERACTION WITH LRP2</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2001" name="EMBO J." volume="20" first="2789" last="2801">
<title>The adaptor molecule Disabled-2 links the transforming growth factor beta receptors to the Smad pathway.</title>
<authorList>
<person name="Hocevar B.A."/>
<person name="Smine A."/>
<person name="Xu X.X."/>
<person name="Howe P.H."/>
</authorList>
<dbReference type="PubMed" id="11387212"/>
<dbReference type="DOI" id="10.1093/emboj/20.11.2789"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SMAD2; SMAD3; TGFBR1 AND TGFBR2</scope>
<scope>MUTAGENESIS OF PHE-166</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="Traffic" volume="3" first="331" last="341">
<title>Myosin VI binds to and localises with Dab2, potentially linking receptor-mediated endocytosis and the actin cytoskeleton.</title>
<authorList>
<person name="Morris S.M."/>
<person name="Arden S.D."/>
<person name="Roberts R.C."/>
<person name="Kendrick-Jones J."/>
<person name="Cooper J.A."/>
<person name="Luzio J.P."/>
<person name="Buss F."/>
</authorList>
<dbReference type="PubMed" id="11967127"/>
<dbReference type="DOI" id="10.1034/j.1600-0854.2002.30503.x"/>
</citation>
<scope>INTERACTION WITH MYO6</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF 684-SER--PHE-686</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="EMBO J." volume="22" first="3084" last="3094">
<title>Regulation of the Wnt signaling pathway by disabled-2 (Dab2).</title>
<authorList>
<person name="Howe P.H."/>
</authorList>
<dbReference type="PubMed" id="12805222"/>
<dbReference type="DOI" id="10.1093/emboj/cdg286"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH DVL3 AND AXIN1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="FEBS Lett." volume="554" first="81" last="87">
<title>Dab2 links CIN85 with clathrin-mediated receptor internalization.</title>
<authorList>
<person name="Kowanetz K."/>
<person name="Terzic J."/>
<person name="Dikic I."/>
</authorList>
<dbReference type="PubMed" id="14596919"/>
<dbReference type="DOI" id="10.1016/s0014-5793(03)01111-6"/>
</citation>
<scope>INTERACTION WITH SH3KBP1</scope>
<scope>MUTAGENESIS OF ARG-720</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="Biochimie" volume="86" first="179" last="182">
<title>The adaptor disabled-2 binds to the third psi xNPxY sequence on the cytoplasmic tail of megalin.</title>
<authorList>
<person name="Gallagher H."/>
<person name="Oleinikov A.V."/>
<person name="Fenske C."/>
<person name="Newman D.J."/>
</authorList>
<dbReference type="PubMed" id="15134832"/>
<dbReference type="DOI" id="10.1016/j.biochi.2004.03.001"/>
</citation>
<scope>INTERACTION WITH LRP2</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2005" name="Cancer Res." volume="65" first="9906" last="9913">
<title>The role of DOC-2/DAB2 in modulating androgen receptor-mediated cell growth via the nongenomic c-Src-mediated pathway in normal prostatic epithelium and cancer.</title>
<authorList>
<person name="Zhoul J."/>
<person name="Hernandez G."/>
<person name="Tu S.W."/>
<person name="Huang C.L."/>
<person name="Tseng C.P."/>
<person name="Hsieh J.T."/>
</authorList>
<dbReference type="PubMed" id="16267015"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-05-1481"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="J. Cell Sci." volume="119" first="4235" last="4246">
<title>The adaptor protein Dab2 sorts LDL receptors into coated pits independently of AP-2 and ARH.</title>
<authorList>
<person name="Maurer M.E."/>
<person name="Cooper J.A."/>
</authorList>
<dbReference type="PubMed" id="16984970"/>
<dbReference type="DOI" id="10.1242/jcs.03217"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-401</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-401</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="FEBS Lett." volume="583" first="1337" last="1343">
<title>Focal adhesion disassembly requires clathrin-dependent endocytosis of integrins.</title>
<authorList>
<person name="Chao W.T."/>
<person name="Kunz J."/>
</authorList>
<dbReference type="PubMed" id="19306879"/>
<dbReference type="DOI" id="10.1016/j.febslet.2009.03.037"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-401</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="5392" last="5403">
<title>Negative regulation of the endocytic adaptor disabled-2 (Dab2) in mitosis.</title>
<authorList>
<person name="Chetrit D."/>
<person name="Barzilay L."/>
<person name="Horn G."/>
<person name="Bielik T."/>
<person name="Smorodinsky N.I."/>
<person name="Ehrlich M."/>
</authorList>
<dbReference type="PubMed" id="21097498"/>
<dbReference type="DOI" id="10.1074/jbc.m110.161851"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2012" name="Biochem. J." volume="441" first="633" last="643">
<title>Dab2 is a key regulator of endocytosis and post-endocytic trafficking of the cystic fibrosis transmembrane conductance regulator.</title>
<authorList>
<person name="Fu L."/>
<person name="Rab A."/>
<person name="Tang L.P."/>
<person name="Rowe S.M."/>
<person name="Bebok Z."/>
<person name="Collawn J.F."/>
</authorList>
<dbReference type="PubMed" id="21995445"/>
<dbReference type="DOI" id="10.1042/bj20111566"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2012" name="EMBO J." volume="31" first="2336" last="2349">
<title>Disabled-2 (Dab2) inhibits Wnt/beta-catenin signalling by binding LRP6 and promoting its internalization through clathrin.</title>
<authorList>
<person name="Jiang Y."/>
<person name="He X."/>
<person name="Howe P.H."/>
</authorList>
<dbReference type="PubMed" id="22491013"/>
<dbReference type="DOI" id="10.1038/emboj.2012.83"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH LRP6</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2012" name="Mol. Biol. Cell" volume="23" first="1330" last="1342">
<title>FCH domain only-2 organizes clathrin-coated structures and interacts with Disabled-2 for low-density lipoprotein receptor endocytosis.</title>
<authorList>
<person name="Mulkearns E.E."/>
<person name="Cooper J.A."/>
</authorList>
<dbReference type="PubMed" id="22323290"/>
<dbReference type="DOI" id="10.1091/mbc.e11-09-0812"/>
</citation>
<scope>FUNCTION IN ENDOCYTOSIS</scope>
<scope>INTERACTION WITH FCHO2</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2012" name="Nat. Cell Biol." volume="14" first="488" last="501">
<title>Distinct and separable activities of the endocytic clathrin-coat components Fcho1/2 and AP-2 in developmental patterning.</title>
<authorList>
<person name="Umasankar P.K."/>
<person name="Sanker S."/>
<person name="Thieman J.R."/>
<person name="Chakraborty S."/>
<person name="Wendland B."/>
<person name="Tsang M."/>
<person name="Traub L.M."/>
</authorList>
<dbReference type="PubMed" id="22484487"/>
<dbReference type="DOI" id="10.1038/ncb2473"/>
</citation>
<scope>INTERACTION WITH FCHO1</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-401; SER-675 AND SER-723</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="29">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-401</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<comment type="function">
<text evidence="15 17 20 21 22 23 24 26">Adapter protein that functions as clathrin-associated sorting protein (CLASP) required for clathrin-mediated endocytosis of selected cargo proteins. Can bind and assemble clathrin, and binds simultaneously to phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) and cargos containing non-phosphorylated NPXY internalization motifs, such as the LDL receptor, to recruit them to clathrin-coated pits. Can function in clathrin-mediated endocytosis independently of the AP-2 complex. Involved in endocytosis of integrin beta-1; this function seems to redundant with the AP-2 complex and seems to require DAB2 binding to endocytosis accessory EH domain-containing proteins such as EPS15, EPS15L1 and ITSN1. Involved in endocytosis of cystic fibrosis transmembrane conductance regulator/CFTR. Involved in endocytosis of megalin/LRP2 lipoprotein receptor during embryonal development. Required for recycling of the TGF-beta receptor. Involved in CFTR trafficking to the late endosome. Involved in several receptor-mediated signaling pathways. Involved in TGF-beta receptor signaling and facilitates phosphorylation of the signal transducer SMAD2. Mediates TFG-beta-stimulated JNK activation. May inhibit the canoniocal Wnt/beta-catenin signaling pathway by stabilizing the beta-catenin destruction complex through a competing association with axin preventing its dephosphorylation through protein phosphatase 1 (PP1). Sequesters LRP6 towards clathrin-mediated endocytosis, leading to inhibition of Wnt/beta-catenin signaling. May activate non-canonical Wnt signaling. In cell surface growth factor/Ras signaling pathways proposed to inhibit ERK activation by interrupting the binding of GRB2 to SOS1 and to inhibit SRC by preventing its activating phosphorylation at 'Tyr-419'. Proposed to be involved in modulation of androgen receptor (AR) signaling mediated by SRC activation; seems to compete with AR for interaction with SRC. Plays a role in the CSF-1 signal transduction pathway. Plays a role in cellular differentiation. Involved in cell positioning and formation of visceral endoderm (VE) during embryogenesis and proposed to be required in the VE to respond to Nodal signaling coming from the epiblast. Required for the epithelial to mesenchymal transition, a process necessary for proper embryonic development. May be involved in myeloid cell differentiation and can induce macrophage adhesion and spreading. May act as a tumor suppressor.</text>
</comment>
<comment type="subunit">
<text evidence="14 15 16 17 18 19 24 25 26 30">Interacts (via NPXY motif) with DAB2 (via PID domain). Can interact (via PID domain) with LDLR, APP, APLP1 and APLP2, and weakly with INPP5D (via NPXY motifs); the interaction is impaired by tyrosine phosphorylation of the respective NPXY motifs. Can weakly interact (via PID domain) with LRP1 (via NPXY motif); the interaction is enhanced by tyrosine phosphorylation of the NPXY motif. Interacts with LRP2 (via NPXY motif); the interaction is not affected by tyrosine phosphorylation of the NPXY motif. Interacts with clathrin; in vitro can assemble clathrin triskelia into polyhedral coats. Interacts with AP2A2, ITGB1, ITGB3, ITGB5, PIAS2, DAB2IP, NOSTRIN, FCHO1, DVL3, EPS15, ITSN1 and EPS15L1. Interacts with SH3KBP1 (via SH3 domains). Interacts with GRB2; competes with SOS1 for binding to GRB2 and the interaction is enhanced by EGF and NT-3 stimulation. Interacts with MAP3K7; the interaction is induced by TGF-beta stimulation and may mediate TGF-beta stimulated JNK activation. Interacts with AXIN1 and PPP1CA; the interactions are mutually exclusive. Interacts with the globular tail of MYO6. Interacts (via DPF motifs) with FCHO2; the interaction is direct and required for DAB2-mediated LDLR endocytosis. Interacts with LRP6; the interaction involves LRP6 phosphorylation by CK2 and sequesters LRP6 towards clathrin-mediated endocytosis. Associates with the TGF-beta receptor complex (Probable). Interacts with SMAD2 and SMAD3; the interactions are enhanced upon TGF-beta stimulation. Interacts with GRB2; the interaction is enhanced by EGF and NT-3 stimulation. Interacts with SRC; the interaction is enhanced by EGF stimulation.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1171238">
<id>P98082</id>
</interactant>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1171238">
<id>P98082</id>
</interactant>
<interactant intactId="EBI-910915">
<id>O75581</id>
<label>LRP6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>20</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1171238">
<id>P98082</id>
</interactant>
<interactant intactId="EBI-350606">
<id>Q9UM54</id>
<label>MYO6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1171238">
<id>P98082</id>
</interactant>
<interactant intactId="EBI-389883">
<id>P16333</id>
<label>NCK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1171238">
<id>P98082</id>
</interactant>
<interactant intactId="EBI-1040141">
<id>Q15796</id>
<label>SMAD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1171238">
<id>P98082</id>
</interactant>
<interactant intactId="EBI-347161">
<id>P84022</id>
<label>SMAD3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15804617">
<id>P98082-1</id>
</interactant>
<interactant intactId="EBI-15804516">
<id>Q29122</id>
<label>MYO6</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasmic vesicle</location>
<location>Clathrin-coated vesicle membrane</location>
</subcellularLocation>
<subcellularLocation>
<location>Membrane</location>
<location>Clathrin-coated pit</location>
</subcellularLocation>
<text>Colocalizes with large insert-containing isoforms of MYO6 at clathrin-coated pits/vesicles. During mitosis is progressively displaced from the membrane and translocated to the cytoplasm.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P98082-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P98082-2</id>
<name>2</name>
<sequence type="described" ref="VSP_004181"/>
</isoform>
<isoform>
<id>P98082-3</id>
<name>3</name>
<sequence type="described" ref="VSP_038401"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="13 19 27">Expressed in deep invaginations, inclusion cysts and the surface epithelial cells of the ovary. Also expressed in breast epithelial cells, spleen, thymus, prostate, testis, macrophages, fibroblasts, lung epithelial cells, placenta, brain stem, heart and small intestine. Expressed in kidney proximal tubular epithelial cells (at protein level).</text>
</comment>
<comment type="domain">
<text evidence="9">The PID domain binds to predominantly non-phosphorylated NPXY internalization motifs present in members of the LDLR and APP family; it also mediates simultaneous binding to phosphatidylinositol 4,5-bisphosphate.</text>
</comment>
<comment type="domain">
<text evidence="9">The Asn-Pro-Phe (NPF) motifs, which are found in proteins involved in the endocytic pathway, mediate the interaction with the EH domain of EPS15, EPS15R and ITSN1.</text>
</comment>
<comment type="PTM">
<text evidence="9">Phosphorylated. Phosphorylation during mitosis is leading to membrane displacement (By similarity).</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/DAB2ID40258ch5p13.html"/>
</comment>
<dbReference type="EMBL" id="U39050">
<property type="protein sequence ID" value="AAC50824.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AH003698">
<property type="protein sequence ID" value="AAB19032.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U53446">
<property type="protein sequence ID" value="AAA98975.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF188298">
<property type="protein sequence ID" value="AAF05540.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF205890">
<property type="protein sequence ID" value="AAF23161.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC008916">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471119">
<property type="protein sequence ID" value="EAW55989.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC003064">
<property type="protein sequence ID" value="AAH03064.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L16886">
<property type="protein sequence ID" value="AAA93195.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS34149.1">
<molecule id="P98082-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS58946.1">
<molecule id="P98082-3"/>
</dbReference>
<dbReference type="PIR" id="G02228">
<property type="entry name" value="G02228"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001231800.1">
<molecule id="P98082-3"/>
<property type="nucleotide sequence ID" value="NM_001244871.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001334.2">
<molecule id="P98082-1"/>
<property type="nucleotide sequence ID" value="NM_001343.3"/>
</dbReference>
<dbReference type="PDB" id="2LSW">
<property type="method" value="NMR"/>
<property type="chains" value="A=24-58"/>
</dbReference>
<dbReference type="PDB" id="6O5O">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A/B=31-191"/>
</dbReference>
<dbReference type="PDB" id="6OVF">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A/B=31-191"/>
</dbReference>
<dbReference type="PDBsum" id="2LSW"/>
<dbReference type="PDBsum" id="6O5O"/>
<dbReference type="PDBsum" id="6OVF"/>
<dbReference type="BMRB" id="P98082"/>
<dbReference type="SMR" id="P98082"/>
<dbReference type="BioGRID" id="107971">
<property type="interactions" value="103"/>
</dbReference>
<dbReference type="DIP" id="DIP-45617N"/>
<dbReference type="ELM" id="P98082"/>
<dbReference type="IntAct" id="P98082">
<property type="interactions" value="64"/>
</dbReference>
<dbReference type="MINT" id="P98082"/>
<dbReference type="STRING" id="9606.ENSP00000313391"/>
<dbReference type="iPTMnet" id="P98082"/>
<dbReference type="MetOSite" id="P98082"/>
<dbReference type="PhosphoSitePlus" id="P98082"/>
<dbReference type="BioMuta" id="DAB2"/>
<dbReference type="DMDM" id="145559465"/>
<dbReference type="EPD" id="P98082"/>
<dbReference type="jPOST" id="P98082"/>
<dbReference type="MassIVE" id="P98082"/>
<dbReference type="MaxQB" id="P98082"/>
<dbReference type="PaxDb" id="P98082"/>
<dbReference type="PeptideAtlas" id="P98082"/>
<dbReference type="PRIDE" id="P98082"/>
<dbReference type="ProteomicsDB" id="57786">
<molecule id="P98082-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="57787">
<molecule id="P98082-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="57788">
<molecule id="P98082-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="3987">
<property type="antibodies" value="299 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="1601"/>
<dbReference type="Ensembl" id="ENST00000320816">
<molecule id="P98082-1"/>
<property type="protein sequence ID" value="ENSP00000313391"/>
<property type="gene ID" value="ENSG00000153071"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000339788">
<molecule id="P98082-2"/>
<property type="protein sequence ID" value="ENSP00000345508"/>
<property type="gene ID" value="ENSG00000153071"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000509337">
<molecule id="P98082-3"/>
<property type="protein sequence ID" value="ENSP00000426245"/>
<property type="gene ID" value="ENSG00000153071"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000545653">
<molecule id="P98082-3"/>
<property type="protein sequence ID" value="ENSP00000439919"/>
<property type="gene ID" value="ENSG00000153071"/>
</dbReference>
<dbReference type="GeneID" id="1601"/>
<dbReference type="KEGG" id="hsa:1601"/>
<dbReference type="UCSC" id="uc003jlw.4">
<molecule id="P98082-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1601"/>
<dbReference type="DisGeNET" id="1601"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000153071.14"/>
<dbReference type="GeneCards" id="DAB2"/>
<dbReference type="HGNC" id="HGNC:2662">
<property type="gene designation" value="DAB2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000153071">
<property type="expression patterns" value="Tissue enhanced (placenta)"/>
</dbReference>
<dbReference type="MIM" id="601236">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P98082"/>
<dbReference type="OpenTargets" id="ENSG00000153071"/>
<dbReference type="PharmGKB" id="PA27132"/>
<dbReference type="eggNOG" id="KOG3535">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000155567"/>
<dbReference type="HOGENOM" id="CLU_020747_1_0_1"/>
<dbReference type="InParanoid" id="P98082"/>
<dbReference type="KO" id="K12475"/>
<dbReference type="OMA" id="GKQFDQI"/>
<dbReference type="PhylomeDB" id="P98082"/>
<dbReference type="TreeFam" id="TF316724"/>
<dbReference type="PathwayCommons" id="P98082"/>
<dbReference type="Reactome" id="R-HSA-190873">
<property type="pathway name" value="Gap junction degradation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-196025">
<property type="pathway name" value="Formation of annular gap junctions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8856825">
<property type="pathway name" value="Cargo recognition for clathrin-mediated endocytosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8856828">
<property type="pathway name" value="Clathrin-mediated endocytosis"/>
</dbReference>
<dbReference type="SignaLink" id="P98082"/>
<dbReference type="SIGNOR" id="P98082"/>
<dbReference type="BioGRID-ORCS" id="1601">
<property type="hits" value="5 hits in 877 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="DAB2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="DAB2"/>
<dbReference type="GenomeRNAi" id="1601"/>
<dbReference type="Pharos" id="P98082">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P98082"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="RNAct" id="P98082">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000153071">
<property type="expression patterns" value="Expressed in placenta and 240 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P98082">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P98082">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005905">
<property type="term" value="C:clathrin-coated pit"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030136">
<property type="term" value="C:clathrin-coated vesicle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030665">
<property type="term" value="C:clathrin-coated vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0001650">
<property type="term" value="C:fibrillar center"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005765">
<property type="term" value="C:lysosomal membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0038024">
<property type="term" value="F:cargo receptor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035615">
<property type="term" value="F:clathrin adaptor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046332">
<property type="term" value="F:SMAD binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0035026">
<property type="term" value="P:leading edge cell differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061024">
<property type="term" value="P:membrane organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007275">
<property type="term" value="P:multicellular organism development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0060766">
<property type="term" value="P:negative regulation of androgen receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090090">
<property type="term" value="P:negative regulation of canonical Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032091">
<property type="term" value="P:negative regulation of protein binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903077">
<property type="term" value="P:negative regulation of protein localization to plasma membrane"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000370">
<property type="term" value="P:positive regulation of clathrin-dependent endocytosis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000643">
<property type="term" value="P:positive regulation of early endosome to late endosome transport"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045807">
<property type="term" value="P:positive regulation of endocytosis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010718">
<property type="term" value="P:positive regulation of epithelial to mesenchymal transition"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010862">
<property type="term" value="P:positive regulation of pathway-restricted SMAD protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032436">
<property type="term" value="P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060391">
<property type="term" value="P:positive regulation of SMAD protein signal transduction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030511">
<property type="term" value="P:positive regulation of transforming growth factor beta receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000096">
<property type="term" value="P:positive regulation of Wnt signaling pathway, planar cell polarity pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0015031">
<property type="term" value="P:protein transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006898">
<property type="term" value="P:receptor-mediated endocytosis"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016055">
<property type="term" value="P:Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="Gene3D" id="2.30.29.30">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR011993">
<property type="entry name" value="PH-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR006020">
<property type="entry name" value="PTB/PI_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF00640">
<property type="entry name" value="PID"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00462">
<property type="entry name" value="PTB"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS01179">
<property type="entry name" value="PID"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0168">Coated pit</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0254">Endocytosis</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0653">Protein transport</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<keyword id="KW-0879">Wnt signaling pathway</keyword>
<feature type="initiator methionine" description="Removed" evidence="5">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Disabled homolog 2" id="PRO_0000079770">
<location>
<begin position="2"/>
<end position="770"/>
</location>
</feature>
<feature type="domain" description="PID" evidence="12">
<location>
<begin position="45"/>
<end position="196"/>
</location>
</feature>
<feature type="region of interest" description="Required for localization to clathrin-coated pits" evidence="9">
<location>
<begin position="230"/>
<end position="447"/>
</location>
</feature>
<feature type="region of interest" description="Sufficient for interaction with GRB2" evidence="9">
<location>
<begin position="604"/>
<end position="732"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with CSK" evidence="9">
<location>
<begin position="619"/>
<end position="627"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with MYO6" evidence="9">
<location>
<begin position="649"/>
<end position="770"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with GRB2 and CSK" evidence="9">
<location>
<begin position="663"/>
<end position="671"/>
</location>
</feature>
<feature type="region of interest" description="Sufficient for interaction with SH3KBP1 SH3 domain" evidence="9">
<location>
<begin position="709"/>
<end position="725"/>
</location>
</feature>
<feature type="short sequence motif" description="DPF 1">
<location>
<begin position="293"/>
<end position="295"/>
</location>
</feature>
<feature type="short sequence motif" description="DPF 2">
<location>
<begin position="298"/>
<end position="300"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylserine" evidence="5">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="11">
<location>
<position position="170"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="193"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; in mitosis" evidence="10">
<location>
<position position="326"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; in mitosis" evidence="10">
<location>
<position position="328"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 4 6 7 8">
<location>
<position position="401"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="675"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="723"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="729"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_038401" evidence="28 29">
<location>
<begin position="209"/>
<end position="229"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_004181" evidence="30">
<location>
<begin position="230"/>
<end position="447"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs700241." id="VAR_031705">
<original>T</original>
<variation>I</variation>
<location>
<position position="586"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3733801." id="VAR_050942">
<original>S</original>
<variation>N</variation>
<location>
<position position="634"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs TGF-beta receptor signaling, no effect on interaction with SMAD2." evidence="15">
<original>F</original>
<variation>A</variation>
<location>
<position position="166"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduced binding to MYO6." evidence="16">
<original>SYF</original>
<variation>AAA</variation>
<location>
<begin position="684"/>
<end position="686"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with SH3KBP1." evidence="18">
<original>R</original>
<variation>A</variation>
<location>
<position position="720"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; AAA93195." ref="8" evidence="30">
<original>KGDG</original>
<variation>PRVC</variation>
<location>
<begin position="44"/>
<end position="47"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC50824/AAB19032, 2; AAA98975, 4; AAF23161 and 8; AAA93195." ref="1 2 4 8" evidence="30">
<original>A</original>
<variation>R</variation>
<location>
<position position="82"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA98975." ref="2" evidence="30">
<original>A</original>
<variation>T</variation>
<location>
<position position="148"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA98975." ref="2" evidence="30">
<original>M</original>
<variation>R</variation>
<location>
<position position="197"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAF05540 and 8; AAA93195." ref="3 8" evidence="30">
<original>ESK</original>
<variation>VCF</variation>
<location>
<begin position="230"/>
<end position="232"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC50824." ref="1" evidence="30">
<original>L</original>
<variation>S</variation>
<location>
<position position="275"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; AAA93195." ref="8" evidence="30">
<original>QPD</original>
<variation>HTR</variation>
<location>
<begin position="302"/>
<end position="304"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAF05540." ref="3" evidence="30">
<original>L</original>
<variation>Q</variation>
<location>
<position position="498"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="29"/>
<end position="31"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="36"/>
<end position="43"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="44"/>
<end position="46"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="48"/>
<end position="59"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="61"/>
<end position="63"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="66"/>
<end position="85"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="91"/>
<end position="98"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="101"/>
<end position="106"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="107"/>
<end position="109"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="112"/>
<end position="116"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="118"/>
<end position="120"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="121"/>
<end position="126"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="133"/>
<end position="138"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="145"/>
<end position="153"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="156"/>
<end position="180"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2LSW"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6O5O"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250"/>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O88797"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P98078"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00148"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10340382"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10769163"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11387212"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11967127"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12805222"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14596919"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15134832"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16267015"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16984970"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19306879"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21995445"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22323290"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22484487"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22491013"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9620555"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10340382"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11161789"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000305"/>
<sequence length="770" mass="82448" checksum="5B2F8B510A580A77" modified="2007-04-17" version="3">MSNEVETSATNGQPDQQAAPKAPSKKEKKKGPEKTDEYLLARFKGDGVKYKAKLIGIDDVPDARGDKMSQDSMMKLKGMAAAGRSQGQHKQRIWVNISLSGIKIIDEKTGVIEHEHPVNKISFIARDVTDNRAFGYVCGGEGQHQFFAIKTGQQAEPLVVDLKDLFQVIYNVKKKEEEKKKIEEASKAVENGSEALMILDDQTNKLKSGVDQMDLFGDMSTPPDLNSPTESKDILLVDLNSEIDTNQNSLRENPFLTNGITSCSLPRPTPQASFLPENAFSANLNFFPTPNPDPFRDDPFTQPDQSTPSSFDSLKSPDQKKENSSSSSTPLSNGPLNGDVDYFGQQFDQISNRTGKQEAQAGPWPFSSSQTQPAVRTQNGVSEREQNGFSVKSSPNPFVGSPPKGLSIQNGVKQDLESSVQSSPHDSIAIIPPPQSTKPGRGRRTAKSSANDLLASDIFAPPVSEPSGQASPTGQPTALQPNPLDLFKTSAPAPVGPLVGLGGVTVTLPQAGPWNTASLVFNQSPSMAPGAMMGGQPSGFSQPVIFGTSPAVSGWNQPSPFAASTPPPVPVVWGPSASVAPNAWSTTSPLGNPFQSNIFPAPAVSTQPPSMHSSLLVTPPQPPPRAGPPKDISSDAFTALDPLGDKEIKDVKEMFKDFQLRQPPAVPARKGEQTSSGTLSAFASYFNSKVGIPQENADHDDFDANQLLNKINEPPKPAPRQVSLPVTKSTDNAFENPFFKDSFGSSQASVASSQPVSSEMYRDPFGNPFA</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

